Utility of Early Post-Treatment Circulating Tumor Tissue Modified Viral HPV DNA Testing in HPV-Associated Oropharyngeal Cancer
Testing for persistent tumor DNA after cancer treatment identifies patients at higher risk of recurrence in oropharyngeal cancer.
This PubMed-indexed retrospective observational/cohort study examined Utility of Early Post-Treatment Circulating Tumor Tissue Modified Viral HPV DNA Testing in HPV-Associated Oropharyngeal Cancer. The abstract reports that persistent positivity identified patients at increased risk, whereas positive results that resolved were not followed by recurrence in this cohort.
What the study was
- Study design
- Retrospective observational/cohort study
- Population
- Utility of Early Post-Treatment Circulating Tumor Tissue Modified Viral HPV DNA Testing in HPV-Associated Oropharyngeal Cancer.
- Sample size
- 332
- Category
- Genomics/Precision Medicine
- Maturity
- Validated
- Journal
- Head & neck
Why it surfaced
Retrospective observational/cohort study with an abstract-supported finding relevant to Precision oncology and genomic medicine; scored conservatively because only the PubMed abstract was reviewed.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.